Outset Medical (OM) Stock Price, News & Analysis

Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Key Stats

• Today's Range: $10.29 to $11.89
• 50-Day Range: $8.25 to $14.40
• 52-Week Range: $5.85 to $78.30
• Volume: 128,536 shs
• Average Volume: 89,178 shs
• Market Capitalization: $41.95 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $67.50
• Consensus Rating: Moderate Buy

Outset Medical Stock Analysis - MarketRank™

Outset Medical scored higher than 23% of companies evaluated by MarketBeat, and ranked 837th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Outset Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Outset Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Outset Medical is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Outset Medical is -4.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Outset Medical has a P/B Ratio of 4.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

21.80% of the float of Outset Medical has been sold short.

Short Interest Ratio / Days to Cover

Outset Medical has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.

Change versus previous month

Short interest in Outset Medical has recently increased by 12.19%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Outset Medical does not currently pay a dividend.

Dividend Growth

Outset Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

21.80% of the float of Outset Medical has been sold short.

Short Interest Ratio / Days to Cover

Outset Medical has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.

Change versus previous month

Short interest in Outset Medical has recently increased by 12.19%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.12

News Sentiment

Outset Medical has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Outset Medical this week, compared to 5 articles on an average week.

Search Interest

6 people have searched for OM on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Outset Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $244,623.00 in company stock.

Percentage Held by Insiders

Only 4.10% of the stock of Outset Medical is held by insiders.

OM Stock Analysis - Frequently Asked Questions

How have OM shares performed this year?

Outset Medical's stock was trading at $16.65 at the start of the year. Since then, OM stock has decreased by 30.6% and is now trading at $11.56.
View the best growth stocks for 2025 here.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) issued its quarterly earnings data on Wednesday, February, 19th. The company reported ($6.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($6.30) by $0.60. The company had revenue of $29.47 million for the quarter, compared to analyst estimates of $28.47 million. Outset Medical had a negative net margin of 112.57% and a negative trailing twelve-month return on equity of 175.64%.

When did Outset Medical's stock split?

Outset Medical's stock reverse split before market open on Thursday, March 20th 2025. The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an initial public offering on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Top institutional investors of Outset Medical include Millennium Management LLC (2.59%), Ensign Peak Advisors Inc (2.40%), Renaissance Technologies LLC (1.28%) and Two Sigma Investments LP (0.91%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Jean-Olivier Racine, Nabeel Ahmed, Marc Nash, John L Brottem, Martin Vazquez, Stacey L Porter and D Keith Grossman.
View institutional ownership trends.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Outset Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Shopify (SHOP), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and

Company Calendar

• Last Earnings: 2/19/2025
• Today: 3/25/2025
• Next Earnings (Estimated): 5/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:OM
• CIK: 1484612
• Web: outsetmedical.com
• Phone: 669-231-8200
• Fax: N/A
• Employees: 520
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $67.50
• High Stock Price Target: $90.00
• Low Stock Price Target: $45.00
• Potential Upside/Downside: +478.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($37.18)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-172,800,000.00
• Net Margins: -112.57%
• Pretax Margin: -122.32%
• Return on Equity: -175.64%
• Return on Assets: -38.61%

Debt

• Debt-to-Equity Ratio: 4.12
• Current Ratio: 6.49
• Quick Ratio: 5.04

Sales & Book Value

• Annual Sales: $113.69 million
• Price / Sales: 0.37
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.45 per share
• Price / Book: 4.76

Miscellaneous

• Outstanding Shares: 3,595,000
• Free Float: 51,502,000
• Market Cap: $41.93 million
• Optionable: Not Optionable
• Beta: 2.01